Clinical Decision Support System (CDSS) is healthcare IT solution that provides evidence-based information to provide optimum care to patient. Clinical decision support system assist healthcare providers, by analyzing of patient data and using that information to aid in diagnosis of specific disease and treatment plan for same. Information input offered by CDSS to clinicians and primary care providers helps to improve the quality of the care by reducing drug overdose, drug interaction, adverse events, and assisting in diagnosis.
Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2054
Market Dynamics
Major driver for growth of the clinical decision support system market is various benefits offered by the CDSS in both inpatient settings, ambulatory settings, and clinics. Medical error is one of the significant contributor to cause of death worldwide. According to data published by Centre for Disease Control and Prevention (CDC), 2013, more than 150,000 deaths are reported annually in the U.S. due to medical error (ADR, wrong diagnosis, prescription error) 
According to World Health Organization (WHO) report, in 2017, medication error costs US$ 42 billion annually worldwide. An estimated 43 million patient safety incidence occur annually and around 1 in 10 patient get harmed due to medication error while receiving healthcare. These incidence of medication error could be addressed with use of CDSS. Increasing prevalence of chronic disease is another driver for wide adoption of CDSS. According to WHO Factsheet, around 73% of global deaths are expected to be from chronic disease by 2020.

Increasing chronic disease prevalence worldwide to propel growth of the clinical decision support system market
Increasing prevalence of the chronic disease such as cancer, diabetes, and cardiovascular disease worldwide is propelling demand for its accurate diagnosis, treatment plan, and continuous care. According to the data published by American Heart Association, in 2016, annual cost of cardiovascular disease and stroke in 2011 – 2012 was US$ 193.1 billion in medical care and about US$ 123 billion in lost productivity from premature death. This cost can be reduced by adopting clinical decision support system, which could prevent and control major risk factors for CVD such as hypertension, hypercholesterolemia, and diabetes.
For More Information @ https://www.coherentmarketinsights.com/market-insight/clinical-decision-and-support-system-market-2054
However, CDSS system has few limitation in its operation, which may hinder growth of the clinical decision support system market.
1. CDSS must integrate with a healthcare provider’s clinical workflow, which is often complex task. Incorporating large amounts of data into existing systems places significant strain on application and infrastructure maintenance
2. Few clinical decision support systems ,which are stand-alone lack facility for integration with EHR system, which may lead to repetition of task
3. Updating development in clinical data on regular basis from ongoing clinical research and medical trials is challenging, as vast number of research and medical trials are being published every day.
Key players are launching new products, which is expected to propel growth of the clinical decision support system market. In February 2018, the US Food and Drug Administration (FDA) granted marketing clearance for Viz.AI's Contact application. It is first Artificial Intelligence-based Clinical Decision Support (CDS) solution approved in the U.S. Integration of the Electronic Health Record(EHR), Computerized Physician Order Entry(CPOE) into CDSS by key players are expected to increase the adoption of the CDSS system, in turn driving growth of the clinical decision support system market. Furthermore, key players are entering into licensing deals with leading hospitals and healthcare groups to expand their consumer base and improve revenue prospects.
Key players operating in the clinical decision support system market include Cerner Corporation, Allscripts Healthcare Solutions, Inc., IBM Watson Health, GE Healthcare, Change Healthcare, Zynx Health, Carestream Health Inc., First Databank, Inc., NextGen Healthcare Information Systems, Agfa Healthcare, Medical Information Technology Inc., Athena Health, Wolters Kluwer NU, Siemens Healthineers, and Philips Healthcare.
Detailed Segmentation:
• Global Clinical Decision Support System Market, By Product:
◦ Stand Alone CDSS
◦ Integrated CDSS
• Global Clinical Decision Support System Market, By Component:
◦ Hardware
◦ Software
◦ Services
• Global Clinical Decision Support System Market, By Delivery Mode:
◦ On Premise CDSS
◦ Web/Cloud based CDSS
• Global Clinical Decision Support System Market, By Applications:
◦ Diagnosis Support
◦ Prescription support
◦ Clinical Reminders and Guidelines
◦ Others

Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/2054

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]